BCHE, butyrylcholinesterase, 590

N. diseases: 392; N. variants: 101
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0233514
Disease: Abnormal behavior
Abnormal behavior
0.020 AlteredExpression phenotype BEFREE Moreover, cholinesterase inhibitors (ChEIs) are the potential class of drugs that can amplify cholinergic activity to improve cognition and global performance and reduce psychiatric and behavioral disturbances. 29770579 2018
CUI: C0233514
Disease: Abnormal behavior
Abnormal behavior
0.020 Biomarker phenotype BEFREE Pooled cholinesterase inhibitors are superior to the placebo in the improvement of cognitive functions, but not behavioral disturbances and they are not well-tolerated, as evaluated by the high discontinuation rate. 30222469 2018
CUI: C4022922
Disease: Abnormal enzyme/coenzyme activity
Abnormal enzyme/coenzyme activity
0.100 Biomarker phenotype HPO
CUI: C4021780
Disease: Abnormality of the liver
Abnormality of the liver
0.100 Biomarker phenotype HPO
CUI: C0278134
Disease: Absence of sensation
Absence of sensation
0.010 GeneticVariation phenotype BEFREE The duration of action of mivacurium was evaluated during a modified neurolept anaesthesia in 17 patients heterozygous for the usual and the atypical plasma cholinesterase (pChe) gene (E1uE1a) and in five patients homozygous for the atypical gene (E1aE1a). 8390770 1993
CUI: C4316903
Disease: Absence Seizures
Absence Seizures
0.300 Therapeutic phenotype CTD_human Design, preparation, and characterization of high-activity mutants of human butyrylcholinesterase specific for detoxification of cocaine. 20971807 2011
CUI: C4316903
Disease: Absence Seizures
Absence Seizures
0.300 Therapeutic phenotype CTD_human Administration of purified human plasma cholinesterase protects against cocaine toxicity in mice. 8667461 1996
CUI: C4316903
Disease: Absence Seizures
Absence Seizures
0.300 Therapeutic phenotype CTD_human Efficacy of human serum butyrylcholinesterase against sarin vapor. 18597747 2008
CUI: C0001175
Disease: Acquired Immunodeficiency Syndrome
Acquired Immunodeficiency Syndrome
0.010 AlteredExpression group BEFREE We wished to ascertain if BChE level is associated with the progression/prognosis of AIDS patients. 29736152 2018
CUI: C0546126
Disease: Acute Confusional Senile Dementia
Acute Confusional Senile Dementia
0.300 Biomarker disease CTD_human Association analysis between K and -116A variants of butyrylcholinesterase and Alzheimer's disease in a Brazilian population. 23022600 2013
CUI: C0856825
Disease: Acute GVH disease
Acute GVH disease
0.010 Biomarker disease BEFREE In conclusion, (1) serum cholinesterase is a simple and reliable marker of acute GVHD and transplant-related complications; and (2) high CHE levels on day +50 predict relapse. 11781614 2001
CUI: C0275518
Disease: Acute infectious disease
Acute infectious disease
0.010 Biomarker group BEFREE Influence of Toxoplasma gondii acute infection on cholinesterase activities of Wistar rats. 24039284 2013
CUI: C3850141
Disease: Acute-On-Chronic Liver Failure
Acute-On-Chronic Liver Failure
0.010 Biomarker disease BEFREE The univariate analysis showed gastrointestinal hemorrhage (P < 0.001), hepatic encephalopathy (P < 0.001), albumin <30 g/L (P < 0.037), creatinine (Cr) >175 µmol/L (P < 0.001), cholinesterase(ChE) activity <3000 U/L (P = 0.019), white blood cell count ≥10 000 (109/L) (P = 0.018), neutrophils ≥80% (P = 0.018), C-reactive protein (CRP) ≥25 mg/L (P < 0.001), procalcitonin ≥1.0 ng/mL (P = 0.007), Child-Pugh class C (P < 0.001), septicemia (P < 0.001), pulmonary infection (P < 0.001),multi-site infection (P = 0.001), acute-on-chronic liver failure (ACLF) (P < 0.001), and advanced hepatocellular carcinoma (HCC) (P < 0.001). 28249358 2017
CUI: C0085281
Disease: Addictive Behavior
Addictive Behavior
0.030 Biomarker phenotype BEFREE In addiction ChE was inhibited in the highest concentrations tested and GST and LDH were induced at 0.79 mg/l, the LOEC registered for TCS in Perez' frogs. 28334672 2017
CUI: C0085281
Disease: Addictive Behavior
Addictive Behavior
0.030 Biomarker phenotype BEFREE In the review articles, renowned researchers in the field capture key mechanisms of cholinergic neurotransmission, from genomic amplification of cholinesterase genes, splicing and post-translational modifications; features of the neuromuscular junction, implications of cholinergic circuitry that are relevant to addiction, anxiety and mood, to preclinical models, protein biomarkers, and clinical findings that are relevant to pathology, for example, developmental neurotoxicity. 28791707 2017
CUI: C0085281
Disease: Addictive Behavior
Addictive Behavior
0.030 GeneticVariation phenotype BEFREE We report here the first investigation to be conducted on the status of BChE activity and the potential association of two BCHE gene SNPs, rs3495 (c.*189G > A) and rs1803274 (c.1699G>A, p.Ala567Thr, K-variant), with addiction vulnerability in heroin, hashish and polydrug users. 30707402 2019
CUI: C0001418
Disease: Adenocarcinoma
Adenocarcinoma
0.020 AlteredExpression group LHGDN Acetyl- and butyrylcholinesterase activities decrease in human colon adenocarcinoma. 17192624 2006
CUI: C0001418
Disease: Adenocarcinoma
Adenocarcinoma
0.020 GeneticVariation group BEFREE Tumorigenic roles were variably suggested for HER-2 and INT-2 oncogene amplifications and the "atypical" aspartate to glycine mutability in the butyrylcholinesterase (BCHE) gene in ovarian adenocarcinomas. 7896186 1995
CUI: C0152013
Disease: Adenocarcinoma of lung (disorder)
Adenocarcinoma of lung (disorder)
0.010 Biomarker disease BEFREE Moreover, at least four genes (MME, SI, BCHE, and KNG) may be involved in the human lung adenocarcinoma cell line OM. 26879013 2016
CUI: C1609524
Disease: ADHF
ADHF
0.020 Biomarker disease BEFREE The aim of this study was to clarify the prognostic significance of CHE concentration and to compare it with other well-established objective nutritional indices in patients with acute decompensated heart failure (ADHF). 31161211 2019
CUI: C1609524
Disease: ADHF
ADHF
0.020 Biomarker disease BEFREE The aim of this study was to clarify the prognostic role of cholinesterase in patients with heart failure with preserved ejection fraction/acute decompensated heart failure and investigate incremental cholinesterase value. 31847660 2020
CUI: C0162309
Disease: Adrenoleukodystrophy
Adrenoleukodystrophy
0.010 AlteredExpression disease BEFREE Importantly, the plasma sST2 levels in ALD patients not only correlated with scores for prognostic models (Maddrey's discriminant function, model for end-stage liver disease and Child-Pugh scores) and indexes for liver function (total bilirubin, international normalized ratio, albumin, and cholinesterase) but also correlated with neutrophil-associated factors as well as some proinflammatory cytokines. 30478965 2019
CUI: C0278878
Disease: Adult Glioblastoma
Adult Glioblastoma
0.010 GeneticVariation disease BEFREE Our findings confirm previous genetic linkage mapping of the functional CHE gene to the 3q26-ter position and demonstrate that extended functional mRNA transcripts encoding a BuChE form with two modified amino acids are produced from this gene in glioblastoma and neuroblastoma cells. 2317787 1990
CUI: C0220630
Disease: Adult Liver Carcinoma
Adult Liver Carcinoma
0.010 AlteredExpression disease BEFREE Herein, we developed an embryonic zebrafish xenograft model using epithelial (Hep3B) and mesenchymal (SKHep1) liver cancer cell lines in wild-type and ache <sup>sb55</sup> sibling mutant larvae after characterization of cholinesterase expression and activity in cell lines and zebrafish larvae. 29371671 2018
CUI: C0041755
Disease: Adverse reaction to drug
Adverse reaction to drug
0.300 Biomarker group CTD_human Grand mal seizures after 2-chloroprocaine epidural anesthesia in a patient with plasma cholinesterase deficiency. 3111302 1987